Due: September 7, 2026 This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular, and circuit substrates of Read More
Due: September 2, 2026 The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Idea Development Award (IDA) supports new ideas that represent innovative approaches to prostate cancer research and have the potential to make Read More
Due: August 10, 2026 JSTO funded activities generate, process, and analyze massive amounts of diverse data. As the complexity of CB defense research grows, encompassing spectral, multi-omics, molecular dynamics, physiological, and epidemiological data, the volume Read More
Anticipated Release Date: Q2 FY27 Next-generation CBRN resilience initiative aimed at delivering threat agnostic host directed medical countermeasures that enhance the body’s ability to withstand, mitigate, and recover from the complex and overlapping physiological impacts Read More
Due: September 30, 2026 The purpose of this broad request for solutions is to solicit innovative proposals for prototype development, demonstration, test and evaluation, analytics, modeling and simulation to address current and future needs for Read More
Due: August 17, 2026 The intent of the Epilepsy Research Program (ERP) Research Partnership Award is to support new or existing research partnerships focused on collaboratively addressing critical questions relevant to post-traumatic epilepsy (PTE) in Read More
Due: August 12, 2026 Chemical and biological threats are becoming more diverse, more sophisticated, and increasingly difficult to detect before they impact military operations, critical infrastructure, public health, or civilian populations. Emerging pathogens, engineered biological Read More
Due: August 13, 2026 The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Exploration – Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in the Multiple Read More
Due: August 6, 2026 The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Idea Development Award (IDA) supports conceptually innovative and high-impact research that could ultimately lead to critical discoveries in tuberous sclerosis Read More
Due: August 6, 2026 The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Translational Research Award (CTRA) supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2026 - All rights reserved.